OGOlga V. Galkina

Olga V. Galkina

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Olga V. Galkina has a total of 105 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Biomarkers of hand osteoarthritis: the key to a personalized algorithm of treatment and diagnostic tactics

    by T. A. Filatova, N. L. Shaporova, O. V. Dudina, O. V. Galkina, A. O. Medvedeva, A. V. Tishkov, N. I. Omirova, E. A. Grigoreva, Т. А. Филатова, Н. Л. Шапорова, et al.

    Introduction. Hand osteoarthritis (HOA) is a poorly studied form of the disease, and biomarkers with diagnostic and prognostic value have not been identified yet. The objective was to study the role of some biomarkers in patients with НОА. Materials and methods. 52 women with НОА were included into the study. The degree of pain, morning stiffness and functional impairment in hand joints was determined in all patients. The laboratory examination included determination of erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), interleukin-1 beta (IL-1β), osteocalcin, cartilage oligomeric matrix protein (COMP) and C-terminal telopeptides of type II collagen in urine (uCTX-II). All women underwent hand joint radiography and densitometry. Results. COMP increase was detected in the «50-65 years» age subgroup, while the values of ESR, CRP, IL-1β, uCTX-II, COMP and osteocalcin in the study group were within the reference range. The use of IL-1β in the diagnosis of НOA is limited by its extremely low concentration in the blood, but the biomarker may be a predictor of a more severe course of the disease in obese patients. No significant correlations were found between the studied biomarkers and functional parameters. In contrast to the body mass index (BMI) and bone mineral density (BMD), age and menopause did not have significant effect on the studied parameters. Conclusions . The determination of uCTX-II and COMP is potentially useful in the diagnosis of not only НOA in general, but also the osteoporotic phenotype of НOA in particular.

  • Tryptophan metabolism is altered in immunoglobulin A nephropathy and is associated with clinical manifestations of the disease

    by Z. Sh. Kochoyan, E. I. Savelieva, M. D. Shachneva, T. I. Alyushina, O. V. Galkina, V. A. Dobronravov

    Background : the catabolism of aromatic amino acids is closely linked to the immune response. Their metabolites act as molecular messengers, facilitating communication between the microbiome and the immune system. Selected studies suggested that the pathogenesis of immunoglobulin A nephropathy (IgAN) may be associated with alterations in tryptophan (Trp) metabolic pathways. Aim : to test the hypothesis about probable changes in Trp metabolism in IgAN using untargeted and targeted metabolomics analyses. Materials and methods : the cohort study included 113 patients with a clinical and morphological diagnosis of primary IgAN, comprised two subgroups: with an active/progressive process who did not receive treatment (IgAN-A, n=85); with inactive IgAN/remission (IgAN-R, n=28). Control groups included healthy volunteers without kidney disease (K1, n=31) and patients with non-inflammatory glomerulopathies (K2, n=33). Untargeted and targeted metabolomics studies of serum were performed using high-resolution high-performance liquid chromatography with mass spectrometric detection (HPLC-MS) in positive and negative ionisation mode. Intergroup differences in Trp metabolites were assessed, and their associations with clinical parameters were analysed. Results : untargeted analysis of mass spectrometric data revealed that tryptophan synthesis and metabolism were enriched among other metabolic pathways in patients with IgAN. Significant differences were found in kynurenic acid (KynA), kynurenine (Kyn), 5-hydroxytryptophan (HTrp), 3-hydroxyanthranilic acid, tryptamine, and indole-3-lactic acid (ILA), suggesting alterations in the serotonin, kynurenine, and indole metabolic pathways. Targeted analyses showed that Trp and its metabolites’ levels differed significantly in patients with IgAN (overall group, n=113) compared to healthy controls. Compared with the IgA-R subgroup, subjects with IgAN-A had higher levels of KynA:Kyn, Kyn:Trp, KynA:Trp, and HTrp:Trp ratios, alongside decreased tryptophan and indoxyacetic acid (IAA). In the IgAN-A group, diverse associations of Trp and its metabolites with clinical parameters were revealed. Except for Trp and indole acetate, metabolites of the Trp pathway were negatively correlated with estimated glomerular filtration rate (eGFR), blood pressure, and age. Tryptophan and indole acetate had negative associations with proteinuria and positive associations with serum albumin levels. Tryptophan and IAA concentrations were inversely associated with proteinuria and directly with serum albumin levels; the associations of these clinical indicators and the ratios of HTrp, Kyn, KynA, NA and ILA to tryptophan were opposite. Conclusions : In IgAN patients, apparent alterations in tryptophan metabolic pathways are associated with clinical parameters and may contribute to the pathogenesis of the disease.

  • The factor of massive infusions as a modifier of cyclophosphamide cardiotoxicity: a comprehensive analysis of cardiomyopathy predictors

    by V. A. Shurakova, A. N. Kulikov, A. Yu. Polushin, O. V. Galkina, A. O. Anpilova, M. A. Gorodnova, E. A. Borovskaya, A. L. Bobrov

    BACKGROUND . High-dose immunosuppressive therapy (HDIT) with autologous hematopoietic stem cell transplantation (AHSCT) is an effective treatment for resistant autoimmune diseases. However, the use of high-dose cyclophosphamide (CP) is associated with the risk of developing cyclophosphamide-induced cardiomyopathy (CIC). Massive infusion therapy may potentiate CP cardiotoxicity, but its role remains insufficiently studied. THE AIM : to assess the contribution of infusion load to the development of CP cardiomyopathy and to find an early signs of its development. PATIENTS AND METHODS . A prospective study was conducted involving 74 patients with multiple sclerosis receiving HDIT-AHSCT and 6 healthy volunteers. Comprehensive clinical, laboratory, and echocardiographic examinations were performed before, on the 3rd, and on the 7th day of therapy. RESULTS. In healthy individuals, infusions caused a transient elevation of NT-proBNP (max. 533.9 pg/ml) accompanied by an increase in heart chamber volumes and a rise in E/e'. Patients developed specific signs of cardiotoxicity: thickening of the walls and an increase in left ventricular (LV) myocardial mass. An NT-proBNP level >533.9 pg/ml on day 3 was associated with myocardial remodeling (ΔLV mass 15.94±26.36 g vs. -0.33±12.70 g, p=0.046) and left ventricular diastolic dysfunction (Δ E/e’ 1.21±2.10 vs. -0.19±1.39, p=0.030). Factor analysis identified three key components of cardiotoxicity, explaining 66.9% of the total data variance. CONCLUSION . Massive infusion therapy within the HDIT-AHSCT protocol is a significant factor potentiating CP cardiotoxicity. An NT-proBNP level >533.9 pg/ml and echocardiographic signs of remodeling on day 3 serve as early markers of cardiac damage. Awareness of the CF-induced cardiomyopathy early symptoms will help to accurate identification of high-risk patients for timely prevention.


  • Open Access

    Serum inorganic phosphate is independently associated with left ventricular myocardial mass index in patients with chronic kidney disease stages 1–4

    by E. O. Bogdanova, E. B. Lebedeva, E. N. Levykina, O. V. Galkina, I. M. Zubina, V. A. Dobronravov

    Background . Driven by multiple factors, heart failure is a leading cause of mortality among patients with chronic kidney disease (CKD). The impact of hyperphosphatemia, a hallmark of CKD, on myocardial remodelling has not been investigated. Objective . To assess the association between serum Pi levels and left ventricular mass index (LVMI) in a population of patients with CKD stages 1–4. Design and methods . Thе cross-sectional cohort study included 1,213 patients with CKD (48 % male, mean age 48 ± 16 years, mean estimated glomerular filtration rate (eGFR) 58 (36; 82) ml/min/1,73 m2 ). We evaluated clinical and demographic parameters, echocardiographic measures, serum Pi levels and parameters of its renal excretion, renal electrolyte excretion, proteinuria, and eGFR. The association between serum Pi and LVMI was analysed using adjusted linear and logistic regression models combined with a pseudo-randomisation approach — 1:1 propensity score matching (PSM) and inverse probability of treatment weighting (IPTW). Results . Patients with left ventricular hypertrophy (LVH, n = 571) had higher Pi levels compared to those without LVH (1,31 [1,12–1,43] vs 1,19 [1,09–1,31] mmol/L; p < 0,0001). Multivariable regression analysis showed that Pi was independently associated with LVMI (B = 13,67 ± 3,31; p < 0,0001; adjusted R² = 0,37), independently of other clinical indices. In IPTW and 1 : 1 PSM regression models, the estimated increase of LVMI at serum Pi levels > 1,37 mmol/L ranged from 5,7 to 11,3 g/m². Conclusion . In CKD patients, serum inorganic phosphate concentration can be an independent factor for left ventricular remodelling and represents a potential target for therapeutic interventions to improve cardiovascular outcomes.

  • Remodeling of Intramyocardial Arteries and Myocardium as a Target of Early Chronic Kidney Disease-Mineral and Bone Disorder: an Experimental Study

    by E. O. Bogdanova, A. M. Sadykov, G. T. Ivanova, I. M. Zubina, O. N. Beresneva, O. V. Galkina, V. V. Sharoyko, V. A. Dobronravov

    Introduction. Chronic kidney disease–mineral and bone disorder (CKD-MBD) plays a significant role in causing cardiovascular morbidity and mortality related to CKD. CKD-MBD has been studied during advanced stages when changes in inorganic phosphate (Pi) and its hormonal regulation are obvious. The initial phases of myocardial remodeling (MR) in early CKD-MBD remain poorly understood. Aim. To investigate the molecular and structural alterations in the myocardium and intramyocardial arteries in early-stage CKD-MBD model. Materials and methods. CKD-MBD was modeled using 3/4 nephrectomy in spontaneously hypertensive rats (SHR). Sham-operated rats served as a control. After 2 or 6 months, we assessed renal function, inorganic phosphate (Pi) metabolism, bone, myocardial and vascular histology and histomorphometry and gene profiles for Pi-dependent, pro-hypertrophic and pro-fibrotic signaling pathways in the myocardium. Results. The chronic kidney injury in the applied models corresponded to human CKD grade 1–2 and was accompanied by lower bone turnover with no increase in fibroblast growth factor 23 and parathyroid hormone levels. Myocardial remodeling was characterized by interstitial and perivascular fibrosis, thickening of the intramyocardial artery media, cardiomyocyte hypertrophy and tissue retention of phosphorus. The differences in the expression profiles included genes related to cell differentiation (Lgr4, Dkk1, Sfrp2) , vascularization (Jag1, Fzd2, Ptch1, Bmp4) and fibrosis (Hes1, Jag1, Mapk1/3, Ctnnb1), hypertrophy (Mapk1/3, Hes1, Jag1, Ctnnb1, Ppp3ca) and Pi balance (Ankh, Mapk1/3, Ppp3ca). Conclusion. The early stages of myocardial and vascular remodeling in CKD-MBD are associated with lower bone turnover and myocardial phosphorus accumulation concurrently with altered myocardial gene expression of pathways related to Pi metabolism, vascularization, fibrosis and hypertrophy.

  • Open Access

    Predictive diagnostics for acute kidney injury in patients with acute coronary syndrome through biomarker level measurement

    by E. A. Vorobyev, A. G. Kucher, O. V. Galkina, I. M. Zubina, E. O. Bogdanova, E. N. Levykina

    Предиктивная диагностика острого повреждения почек с применением определения уровня биомаркеров у пациентов с острым коронарным синдромом

  • Microalbuminuria, neutrophil gelatinase-associated lipocalin (NGAL), and kidney injury molecule-1 (KIM-1) as predictors of preeclampsia and gestational diabetes mellitus

    by Vitaliy F. Bezhenar, Olesia A. Grigoreva, Olga V. Galkina, Anastasiia O. Anpilova

    Background: The health of young women of reproductive age is a key factor that directly influences the health of future generations. Therefore, early detection of chronic diseases, including chronic kidney disease, in this category of patients is one of the primary objectives of healthcare services. From an obstetric perspective, preventing chronic kidney disease can be linked to the early detection and prediction of preeclampsia and gestational diabetes mellitus. In the literature, there are studies that investigate microalbuminuria, neutrophil gelatinase-associated lipocalin (NGAL), and kidney injury molecule-1 (KIM-1) as predictors of these obstetric complications. Aim: The aim of this study was to evaluate microalbuminuria, KIM-1, and NGAL as markers for the development of gestational diabetes mellitus and preeclampsia. Materials and methods: This prospective study was conducted at the Department of Obstetrics and Gynecology, Academician I.P. Pavlov First Saint Petersburg State Medical University (Saint Petersburg, Russia) and involved 280 pregnant women during the first trimester at 6-13 weeks of gestation. The concentrations of microalbuminuria, KIM-1, and NGAL were measured. The second stage involved assessing the course of pregnancy and the development of obstetric complications in the participants. ROC analysis was performed to assess biological markers as predictors of preeclampsia, and predictive value was evaluated by the area under the ROC curve. Results: The urinary KIM-1 levels in all patients were within the reference values. Microalbuminuria in the range from 30 to 300 mg/L was detected in 20 patients (7.14%). Gestational diabetes mellitus was more common in patients with microalbuminuria above 30 mg/L (p = 0.0358). Elevated serum NGAL levels above the reference values (106 ng/L) were observed in 96 patients (34.2%). Urinary NGAL levels exceeded 9.8 ng/L in 203 patients (72.5%). Moderate or severe preeclampsia developed in 63 (22.5%) pregnant women. ROC analysis of NGAL’s predictive ability showed high sensitivity and specificity for preeclampsia prediction (sensitivity 95.24%, specificity 93.09%, area under the ROC curve 0.93). Conclusions: The data obtained suggest that the assessment of albuminuria, serum NGAL, and urinary NGAL levels in the blood serum and urine of pregnant women during the first trimester of gestation may serve as early prognostic biomarkers for gestational diabetes mellitus and preeclampsia.

  • Review of domestic test systems for detecting current or past SARS‑CoV‑2 infection using enzyme‑linked immunosorbent assay

    by O. V. Galkina, A. O. Anpilova, E. O. Bogdanova, I. M. Zubina, E. N. Levykina

    Introduction. Rapid and reliable assessment of circulating antibody levels to SARS-CoV-2 remains the current challenge for monitoring and preventing the spread of COVID-19. As the risk of emergence and dissemination of new viral strains continues to grow, epidemiologic research is also becomes increasingly important. The enzyme-linked immunosorbent assay (ELISA) is useful to assess the vaccination effectiveness and the need for revaccination, the proportion of post-disease and vaccinated individuals, and to monitor population immunity. This article provides an overview of the local ELISA kits currently available for the detection of antibodies against SARS-CoV-2 viral proteins, with a comparison to the certified kit by Mediagnost Ltd. (Germany).The aim. Laboratory testing of seven domestic reagent kits for the determination of antibodies to SARS-CoV-2 viral proteins by ELISA in comparison with the certified test system “Anti-SARS-CoV-2 ELISA E 111-IVD” (Mediagnost Ltd., Reutlingen, Germany).Materials and methods. The study included 80 serum samples from conditionally healthy donors: experimental group (n=70, serum samples collected after 2019) and control group (n=10, serum samples collected before 2018). The experimental group is comprised of non-infected and post-disease individuals; a proportion of those were vaccinated against COVID-19.Results and conclusions. The data obtained indicate high reproducibility, sensitivity (100 %), and specificity for all domestic ELISA kits in detecting both post-disease (90–95 %) and vaccinated volunteers (100 %). The main quality criteria of the obtained results were comparable to those for the certified test system, “Anti-SARS-CoV-2 ELISA E 111-IVD” (Mediagnost Ltd., Germany). All kits detecting IgG to the receptor-binding domain (RBD) and to the S-glycoprotein were effective for the reliable assessment of antibody production after the vaccination. Kits for the detection of antibodies to the RBD and/or viral nucleocapsid are useful for identifying unvaccinated post-disease individuals.

  • Open Access

    Asymmetric dimethylarginine as a marker of endothelial dysfunction in patients with type 1 diabetes mellitus with different glycemic variability

    by M.E. Chernaya, Yu.SH. Khalimov, A.R. Volkova, A.A. Mayer, A.A. Nersesyan, O.V. Galkina, A.V. Lisker

    Асимметричный диметиларгинин как маркер дисфункции эндотелия у больных сахарным диабетом 1 типа с различной вариабельностью гликемии

  • Open Access

    The indicators of ovarian reserve in conditions of hyperleptinemia

    by K.V. Azizova, A.R. Volkova, S.V. Dora, O.V. Galkina, T.S. Ermolinskaya

    Показатели овариального резерва в условиях гиперлептинемии